A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Read more about A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care Read more about Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care
A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Read more about A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Point-of-Care Ultrasound Educational Initiative for Insect Bites Read more about Point-of-Care Ultrasound Educational Initiative for Insect Bites
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia Read more about Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma Read more about PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma
Assessment of Financial Difficulty in Participants With Chronic Lymphocytic Leukemia and Multiple Myeloma Read more about Assessment of Financial Difficulty in Participants With Chronic Lymphocytic Leukemia and Multiple Myeloma
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller Read more about A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) Read more about Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Read more about A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa